Association Between Alpha-tocopherol, Gamma-tocopherol, Selenium, and Subsequent Prostate Cancer
Overview
Affiliations
Background: Selenium and alpha-tocopherol, the major form of vitamin E in supplements, appear to have a protective effect against prostate cancer. However, little attention has been paid to the possible role of gamma-tocopherol, a major component of vitamin E in the U.S. diet and the second most common tocopherol in human serum. A nested case-control study was conducted to examine the associations of alpha-tocopherol, gamma-tocopherol, and selenium with incident prostate cancer.
Methods: In 1989, a total of 10,456 male residents of Washington County, MD, donated blood for a specimen bank. A total of 117 of 145 men who developed prostate cancer and 233 matched control subjects had toenail and plasma samples available for assays of selenium, alpha-tocopherol, and gamma-tocopherol. The association between the micronutrient concentrations and the development of prostate cancer was assessed by conditional logistic regression analysis. All statistical tests were two-sided.
Results: The risk of prostate cancer declined, but not linearly, with increasing concentrations of alpha-tocopherol (odds ratio (highest versus lowest fifth) = 0.65; 95% confidence interval = 0.32--1.32; P(trend) =.28). For gamma-tocopherol, men in the highest fifth of the distribution had a fivefold reduction in the risk of developing prostate cancer than men in the lowest fifth (P:(trend) =.002). The association between selenium and prostate cancer risk was in the protective direction with individuals in the top four fifths of the distribution having a reduced risk of prostate cancer compared with individuals in the bottom fifth (P(trend) =.27). Statistically significant protective associations for high levels of selenium and alpha-tocopherol were observed only when gamma-tocopherol concentrations were high.
Conclusions: The use of combined alpha- and gamma- tocopherol supplements should be considered in upcoming prostate cancer prevention trials, given the observed interaction between alpha-tocopherol, gamma-tocopherol, and selenium.
Jang Y, Kim C Nutrients. 2024; 16(23).
PMID: 39683509 PMC: 11644559. DOI: 10.3390/nu16234115.
Dennis L, Langston M, Beane Freeman L, Canales R, Lynch C Curr Oncol. 2024; 31(9):5472-5483.
PMID: 39330033 PMC: 11430890. DOI: 10.3390/curroncol31090405.
Li P, Cui Y, Hu K, Wang X, Yu Y Clin Transl Oncol. 2024; .
PMID: 39251496 DOI: 10.1007/s12094-024-03692-1.
Jeong S, Kim H, Park M, Bhosale P, Abusaliya A, Won C Int J Mol Sci. 2023; 24(11).
PMID: 37298192 PMC: 10252627. DOI: 10.3390/ijms24119240.
Samadzadeh Mamaghani A, Manafi M, Hojjati M IET Nanobiotechnol. 2023; 17(4):337-351.
PMID: 36942592 PMC: 10288361. DOI: 10.1049/nbt2.12126.